Oligonucleotide Array Analysis of the HER2 Amplicon in Breast Cancers

被引：0
|
作者：
Lytvak, I. [1 ]
Gunn, S. R. [1 ]
Yeh, I. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
263
引用
收藏
页码：61A / 61A
页数：1
相关论文
共 50 条
  • [21] Her2/neu status in bone metastases of breast cancers
    Lörincz, T
    Tóth, J
    Szendröi, M
    Tímár, J
    PROCEEDINGS OF THE 2ND CONGRESS OF THE WORLD SOCIETY FOR BREAST HEALTH, 2003, : 35 - 38
  • [22] Adjuvant chemotherapy of breast cancers with overexpression or HER2 amplification
    Petit, Thierry
    ONCOLOGIE, 2008, 10 : S64 - S67
  • [23] HER2 heterogeneity in primary breast cancers: A tissue microarray analysis of FISH and IHC
    Safo, A. O.
    Dolan, M.
    Sweeney, C.
    Blair, C.
    Forsler, C.
    Gulbahce, H. E.
    MODERN PATHOLOGY, 2008, 21 : 53A - 53A
  • [24] The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells - A data description
    Hongisto, Vesa
    Aure, Miriam Ragle
    Makela, Rami
    Sahlberg, Kristine Kleivi
    GENOMICS DATA, 2014, 2 : 249 - 253
  • [25] Analysis of HER2 External Domain Epitopes in Breast and Gastric Cancers Expressing p95HER2
    Daniele, L.
    Recupero, D.
    Viale, G.
    Risio, M.
    Dei Tos, A. P.
    Marchio, C.
    Castellano, I.
    Sapino, A.
    MODERN PATHOLOGY, 2012, 25 : 33A - 33A
  • [26] Analysis of HER2 External Domain Epitopes in Breast and Gastric Cancers Expressing p95HER2
    Daniele, L.
    Recupero, D.
    Viale, G.
    Risio, M.
    Dei Tos, A. P.
    Marchio, C.
    Castellano, I.
    Sapino, A.
    LABORATORY INVESTIGATION, 2012, 92 : 33A - 33A
  • [27] HER2/TOP2A amplicon in breast cancer:: a microarray-based and chromogenic in situ hybridisation analysis
    Arriola, E.
    Lambros, M. B. K.
    Marchio, C.
    Tan, D.
    Natrajan, R.
    Rodrigvez-Pinilla, S. M.
    Tamber, N.
    Fenwick, K.
    Mackay, A.
    Jones, C.
    Dowsett, M.
    Ashworth, A.
    Reis-Filho, J. S.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S285 - S286
  • [28] Array-CGH identifies CCNE1 amplification in ER/HER2 negative breast cancers
    Natrajan, R.
    Rodriguez-Pinilla, S. M.
    Marchio, C.
    Moreno-Bueno, G.
    Vatcheva, R.
    Mahler-Araujo, B.
    Lambros, M. B. K.
    Mackay, V. A.
    Palacios, J.
    Ashworth, A.
    Reis-Filho, J. S.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S285 - S285
  • [29] Correlation of HER2 Immunohistochemical Scores and HER2 mRNA, Oncotype Recurrence Score and Magee Scores on ER Positive, HER2 Negative Breast Cancers
    Tyburski, Haley
    Karakas, Cansu
    Zhang, Huina
    Liu, Elena
    Turner, Bradley
    Hicks, David
    LABORATORY INVESTIGATION, 2023, 103 (03) : S216 - S217
  • [30] Pathological complete response rates in HER2 amplified breast cancers based on levels of HER2 amplification.
    Patel, Ina
    Hashimie, Yasmeen
    Hall, James
    Bhat, Ashwini
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345